Tumour site specific group (TSSG) - Haematology
Professional information site
 

Myeloma: Product documentation and forms

 

Lenalidomide (Revlimid®)


Thalidomide Celgene

General documents

 

Velcade response
scheme (VRS)




Pomalidomide (Imnovid®) 
 



Bortezomib licence and funding summary
 

Return to Myeloma page
 
Return to Home page